Starling Oncology, Inc. (STLN)
6.145
-0.32
(-4.95%)
USD |
NASDAQ |
Aug 24, 16:00
6.145
0.00 (0.00%)
After-Hours: 20:00
Starling Oncology Enterprise Value : 712.91M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 712.91M |
| August 20, 2026 | 720.45M |
| August 19, 2026 | 732.51M |
| August 18, 2026 | 706.38M |
| August 17, 2026 | 697.34M |
| August 14, 2026 | 711.41M |
| August 13, 2026 | 692.32M |
| August 12, 2026 | 698.35M |
| August 11, 2026 | 685.79M |
| August 10, 2026 | 682.27M |
| August 07, 2026 | 707.39M |
| August 06, 2026 | 564.72M |
| August 05, 2026 | 568.74M |
| August 04, 2026 | 582.81M |
| August 03, 2026 | 578.79M |
| July 31, 2026 | 551.66M |
| July 30, 2026 | 572.76M |
| July 29, 2026 | 542.62M |
| July 28, 2026 | 560.70M |
| July 27, 2026 | 584.82M |
| July 24, 2026 | 563.72M |
| July 23, 2026 | 572.76M |
| July 22, 2026 | 594.86M |
| July 21, 2026 | 608.93M |
| July 20, 2026 | 615.96M |
| Date | Value |
|---|---|
| July 17, 2026 | 600.89M |
| July 16, 2026 | 591.85M |
| July 15, 2026 | 632.04M |
| July 14, 2026 | 694.33M |
| July 13, 2026 | 691.31M |
| July 10, 2026 | 655.14M |
| July 09, 2026 | 651.13M |
| July 08, 2026 | 631.03M |
| July 07, 2026 | 646.10M |
| July 06, 2026 | 609.93M |
| July 02, 2026 | 593.86M |
| July 01, 2026 | 616.97M |
| June 30, 2026 | 608.93M |
| June 29, 2026 | 634.43M |
| June 26, 2026 | 613.44M |
| June 25, 2026 | 586.44M |
| June 24, 2026 | 599.44M |
| June 23, 2026 | 577.45M |
| June 22, 2026 | 575.45M |
| June 18, 2026 | 600.44M |
| June 17, 2026 | 599.44M |
| June 16, 2026 | 584.44M |
| June 15, 2026 | 592.44M |
| June 12, 2026 | 605.44M |
| June 11, 2026 | 587.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 2.283B |
| Agilon Health, Inc. | 1.397B |
| Nakamoto, Inc. | 271.97M |
| American Oncology Network, Inc. | -- |
| Sonida Senior Living, Inc. | 3.380B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.241M |
| Revenue (Quarterly) | 161.28M |
| Total Expenses (Quarterly) | 169.52M |
| EPS Diluted (Quarterly) | -0.08 |
| Gross Profit Margin (Quarterly) | 15.70% |
| Profit Margin (Quarterly) | -5.11% |
| Earnings Yield | -4.97% |
| Normalized Earnings Yield | -4.589 |